Hallén J - Search Results

1

Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience.

Hall TS, Hallén J, Agewall S, Atar D, Jensen T. Hall TS, et al. Among authors: hallen j. Clin Lab. 2012;58(9-10):1029-36. Clin Lab. 2012. PMID: 23163120

2

Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.

Hallén J, Sejersten M, Johanson P, Atar D, Clemmensen PM. Hallén J, et al. Am J Cardiol. 2010 May 1;105(9):1223-8. doi: 10.1016/j.amjcard.2009.12.034. Epub 2010 Mar 11. Am J Cardiol. 2010. PMID: 20403470 Clinical Trial.

3

Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Hallén J, Jensen JK, Fagerland MW, Jaffe AS, Atar D. Hallén J, et al. Heart. 2010 Dec;96(23):1892-7. doi: 10.1136/hrt.2009.190819. Heart. 2010. PMID: 21062778 Clinical Trial.

4

A window into your heart: taking cardiac troponin to the next level.

Hallén J, Atar D. Hallén J, et al. Biomark Med. 2010 Dec;4(6):889-94. doi: 10.2217/bmm.10.103. Biomark Med. 2010. PMID: 21133709

5

Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction.

Hallén J, Jensen JK, Buser P, Jaffe AS, Atar D. Hallén J, et al. Acute Card Care. 2011 Mar;13(1):48-51. doi: 10.3109/17482941.2010.538698. Epub 2011 Jan 18. Acute Card Care. 2011. PMID: 21244230

6

Obstructive sleep apnea: no independent association to troponins.

Hall TS, Herrscher T, Jarolim P, Fagerland MW, Jensen T, Hallén J, Agewall S, Atar D. Hall TS, et al. Among authors: hallen j. Sleep Breath. 2014 May;18(2):351-8. doi: 10.1007/s11325-013-0892-6. Epub 2013 Sep 17. Sleep Breath. 2014. PMID: 24043484 Clinical Trial.

7

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agewall S, Atar D, Lincoff AM. Hall TS, et al. Among authors: hallen j. Am Heart J. 2015 Feb;169(2):257-265.e1. doi: 10.1016/j.ahj.2014.10.015. Epub 2014 Nov 4. Am Heart J. 2015. PMID: 25641535 Clinical Trial.

8

In ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention, admission cardiac troponin T and peak cardiac troponin T values differ in their prognostic properties.

Hallén J, Atar D. Hallén J, et al. Am J Cardiol. 2009 May 1;103(9):1331. doi: 10.1016/j.amjcard.2009.02.032. Am J Cardiol. 2009. PMID: 19406285 No abstract available.

9

Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.

Hallén J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D. Hallén J, et al. Am J Cardiol. 2009 Dec 1;104(11):1472-7. doi: 10.1016/j.amjcard.2009.07.019. Epub 2009 Oct 14. Am J Cardiol. 2009. PMID: 19932777

10

Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial.

Hallén J, Petzelbauer P, Schwitter J, Geudelin B, Buser P, Atar D. Hallén J, et al. EuroIntervention. 2010 Apr;5(8):946-52. EuroIntervention. 2010. PMID: 20542780 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters